CME

CME Group Inc.

Financial ServicesFinancial Data & Stock ExchangesNASDAQ

$273.54

-$14.89 (-5.44%)today

Conviction

0/ 10

Fair Value$308.21

Upside+12.68%

Signal0

Market Cap$107.1B

52W Range$248.53–$329.16

Next EarningsApr 22

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$142.08

Current Price$293.78

Upside / Down-51.6%

P(Undervalued)0.0%

P(20%+ Up)0.0%

P(15%+ Down)100.0%

Fair Value Distribution — percentile bands

0.0% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

25.8%/yr

±3.9% · revenue growth to justify current price

FCF-Based Reverse DCF

14.2%/yr

±3.0% · FCF growth to justify current price

THE GAP

Market pricing margin expansion or capex normalization

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Quick Take

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

Trailing P/E27.9x

Forward P/E24.5x

P/S17.4x

EPS (TTM)$11.17

Analyst Target$308.21

Analyst Upside12.7%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10kMar 1

Conviction: unchanged

CME Group FY2025 10-K: 4th Consecutive Record Year — Moat Intact, Valuation Full

CME posted record FY2025 results: .51B revenue (+6.5%), net income .1B, adj. EPS .20 (+15.4%), record ADV of 28.1M contracts (+6%). Business model continues to compound on scale and regulatory tailwin...